Food and Drug Administration, HHS.
Final rule; technical amendment.
The Food and Drug Administration (FDA) is amending its regulations to reflect a change in the address and telephone number for the Office of Combination Products (OCP). This action is editorial in nature and is intended to improve the accuracy of the agency's regulations.
Effective Date: April 19, 2010.Start Further Info
FOR FURTHER INFORMATION CONTACT:
John Barlow Weiner, Office of Combination Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5130, Silver Spring, MD 20993-0002, 301-796-8930. To confirm that this change of address and telephone number has occurred, please see our Web site at www.fda.gov/CombinationProducts/default.htm.End Further Info End Preamble Start Supplemental Information
FDA is amending its regulations in 21 CFR part 3 to reflect a change in the address and telephone number for OCP. Publication of this document constitutes final action on this change under the Administrative Procedure Act (5 U.S.C. 553). Notice and public procedures are unnecessary because FDA is merely updating nonsubstantive content.Start List of Subjects
List of Subjects in 21 CFR Part 3End List of Subjects Start Amendment Part
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs,End Amendment Part Start Part
PART 3—PRODUCT JURISDICTIONEnd Part Start Amendment Part
1. The authority citation forEnd Amendment Part
2. Section 3.6 is amended by removing “(HFG-3), Food and Drug Administration, 15800 Crabbs Branch Way, suite 200, Rockville, MD 20855, 301-427-1934”and by adding in its place “Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5129, Silver Spring, MD 20993-0002, 301-796-8930,”.End Amendment Part Start Signature
Dated: March 17, 2010.
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-6246 Filed 3-22-10; 8:45 am]
BILLING CODE 4160-01-S